Colnaghi MI - Search Results

1

A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.

Morelli D, Pozzi B, Maier JA, Ménard S, Colnaghi MI, Balsari A. Morelli D, et al. Among authors: colnaghi mi. Nucleic Acids Res. 1995 Nov 25;23(22):4603-7. doi: 10.1093/nar/23.22.4603. Nucleic Acids Res. 1995. PMID: 8524649 Free PMC article.

2

An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.

Sardini A, Villa E, Morelli D, Ghione M, Ménard S, Colnaghi MI, Balsari A. Sardini A, et al. Among authors: colnaghi mi. Int J Cancer. 1992 Feb 20;50(4):617-20. doi: 10.1002/ijc.2910500422. Int J Cancer. 1992. PMID: 1537626

3

Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.

Morelli D, Ménard S, Colnaghi MI, Balsari A. Morelli D, et al. Among authors: colnaghi mi. Cancer Res. 1996 May 1;56(9):2082-5. Cancer Res. 1996. PMID: 8616854

4

Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.

Morelli D, Ménard S, Cazzaniga S, Colnaghi MI, Balsari A. Morelli D, et al. Among authors: colnaghi mi. Br J Cancer. 1997;75(5):656-9. doi: 10.1038/bjc.1997.117. Br J Cancer. 1997. PMID: 9043020 Free PMC article.

5

Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigen.

Sfondrini L, Morelli D, Ménard S, Maier J, Singh M, Melani C, Terrazzini N, Colombo M, Colnaghi M, Balsari A. Sfondrini L, et al. Gene Ther. 1998 Feb;5(2):247-52. doi: 10.1038/sj.gt.3300575. Gene Ther. 1998. PMID: 9578845

6

Network of idiotypic and anti-idiotypic antibodies related to the ovarian carcinoma-associated folate binding protein.

Pupa SM, Bazzini P, Menard S, Colnaghi MI. Pupa SM, et al. Among authors: colnaghi mi. Anticancer Res. 1992 Sep-Oct;12(5):1565-70. Anticancer Res. 1992. PMID: 1332580

7

Increase in the therapeutic effect of doxorubicin induced by monoclonal antibodies raised against this drug.

Villa E, Balsari A, Sardini A, Morelli D, Ménard S, Colnaghi MI. Villa E, et al. Among authors: colnaghi mi. Pharmacol Res. 1992 Sep;26 Suppl 2:141-3. doi: 10.1016/1043-6618(92)90636-p. Pharmacol Res. 1992. PMID: 1409283 No abstract available.

8

Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicity.

Canevari S, Mezzanzanica D, Ménard S, Ferrini S, Moretta L, Colnaghi MI. Canevari S, et al. Among authors: colnaghi mi. Int J Cancer Suppl. 1992;7:42-4. Int J Cancer Suppl. 1992. PMID: 1428402 Review.

9

A new monoclonal antibody recognizing anthracyclinic molecule.

Balsari A, Morelli D, Menard S, Tagliabue E, Colnaghi MI, Ghione M. Balsari A, et al. Among authors: colnaghi mi. Anticancer Res. 1990 Jan-Feb;10(1):129-32. Anticancer Res. 1990. PMID: 1692196

10

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.

Pellegrini R, Centis F, Martignone S, Mastroianni A, Tagliabue E, Tosi E, Ménard S, Colnaghi MI. Pellegrini R, et al. Among authors: colnaghi mi. Cancer Immunol Immunother. 1991;34(1):37-42. doi: 10.1007/BF01741322. Cancer Immunol Immunother. 1991. PMID: 1760809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters